+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oxycodone Drug Market 2019-2025

  • PDF Icon


  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129795
Global Oxycodone Drug Market Size, Share & Trends Analysis Report, by Applications (Pain Management, Anesthesia, and Addiction Management), and Forecast Period 2019-2025.

The global oxycodone drug market is estimated to grow at a significant CAGR during the forecast period. The increasing frequency of terminally ill diseases such as cancer and HIV and a high surge in post-operative pain prescribed medication is driving the growth of the global oxycodone drug market. New drug development is a large market opportunity for the oxycodone market. New products with innovations in formulations and drug designing such as abuse-deterrent formulations done in Oxycontin and Opana, fuel the branded opiate market. Moreover, the US Food and Drug Administration is also encouraging drug makers to come up with a new generation drug that is less addictive.

An increase in new drug applications by pharmaceutical companies and the number of products in the pipeline drives the future opportunity growth of the global oxycodone market. Other formulations such as control release of drugs for improved pain management are coming up in the market. Advanced drug formulations such as extended-release medications for pain control are examples of improved formulation driving the market.

The global oxycodone market is segmented into applications into pain management, anesthesia, and de-addiction. Pain management accounts for the largest market portion, owing to the increasing frequency of Parkinson’s syndrome, rheumatic, and cancer patients. Geographically, the global oxycodone drugs market is segmented based on the region including North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The major manufactures of the oxycodone drug include Purdue Pharma L.P, Janssen Pharmaceuticals (A Johnson & Johnson Subsidiary), Inc., Hikma Pharmaceuticals USA, Inc., Pfizer, Inc., Sanofi-Aventis S.A., Sun Pharmaceutical Industries Ltd., and others. The range of oxycodone drugs provided by these companies is Oxynorm, OxyContin, Endone, Proladone, Targin, and more. These companies are receiving approvals for new drugs that are expected to contribute to the oxycodone drug market. For instance, in April 2017, the FDA approved RoxyBond, a new formulation of immediate-release oxycodone. This oxycodone formulation is the first immediate-release opioid analgesic approved with labeling describing its abuse-deterrent properties.

Research Methodology

The market study of the global oxycodone drugs market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include:
  • Reports of companies involved in the market
  • Authentic Public Databases
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog
The report is intended for providers, suppliers, and distributors of fiberglass, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market.

Market Segmentation:
  • Global Oxycodone Drugs Market by Type
  • Global Oxycodone Drugs Market by Application

The Report Covers:
  • Comprehensive research methodology of the global oxycodone drug market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Insights about market determinants which are stimulating the global oxycodone drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusions
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Purdue Pharma L.P Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary) Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Hikma Pharmaceuticals USA, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Pfizer, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. Sanofi-Aventis S.A. Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Oxycodone Drug Market by Application
5.1.1. Pain Management
5.1.2. Anesthesia
5.1.3. Addiction Management
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Allergan PLC
7.2. Endo Pharmaceuticals, Inc.
7.3. Grunenthal GmbH
7.4. Hikma Pharmaceuticals USA, Inc.
7.5. Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
7.6. Pfizer, Inc.
7.7. Purdue Pharma L.P
7.8. Sanofi-Aventis S.A.
7.9. Sun Pharmaceutical Industries Ltd.
7.10. Teva Pharmaceutical Industries Ltd.
7.11. Vistapharm Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Allergan PLC
  • Endo Pharmaceuticals, Inc.
  • Grunenthal GmbH
  • Hikma Pharmaceuticals USA, Inc.
  • Janssen Pharmaceuticals, Inc. (A Johnson & Johnson Subsidiary)
  • Pfizer, Inc.
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vistapharm Inc.